Delivery Order SPE2DB22D3016-SPE2DB25FAVX1

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,752.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a medical product, with a completion date of November 13, 2023. The contract is a Firm Fixed Price (FFP) arrangement and was not designated with a set-aside requirement, indicating open...
This federal contract award, valued at $1,661.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for "ESTROGEN-METHYLTESTOS F.S. TAB 100S" and has an ultimate completion date of August 28, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,045.93, is a Firm Fixed Price Delivery Order to provide "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical supplies. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award, valued at $1,318.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a medical product, and has an ultimate completion date of June 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.74 firm fixed-price delivery order is for the supply of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a medical commodity. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,074.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of medical supplies, specifically "ESTROGEN-METHYLTESTOS H.S. TAB 100S", to support federal healthcare programs, including military treatment facilities and veteran's healthcare services. The contract is a delivery order with a firm fixed price, and it has a completion date of January 7,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.12 firm-fixed-price delivery order is for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S" medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $2,618.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrogen-Methyltestos H.S. Tab 100s, a pharmaceutical product, with an ultimate completion date of April 22, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,078.12 firm fixed-price contract is a delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of "ESTROGEN-METHYLTESTOS H.S. TAB 100S", a pharmaceutical product,...
This federal contract award, valued at $1,381.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVX1
    Delivery Order

This federal contract award, valued at $1,014.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FAVX1) for the supply of "ESTROGEN-METHYLTESTOS H.S. TAB 100S," a pharmaceutical product. The contract is a firm fixed-price arrangement with a performance period ending on May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of medical products and supplies to military healthcare programs and other government agencies.

Generated 8/6/25, 10:01 AM